4 Results for "

chimeric antigen receptor T (CAR-T)

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "chimeric antigen receptor T (CAR-T)" in MCE Product Catalog:

Cat. No.: HY-P99825
CAS No.: 2171034-70-9

Target:  

Inhibitory Antibodies

Research Areas:  

Inflammation/Immunology Cancer

Relfovetmab is a monoclonal antibody and also serves as a single-chain variable fragment component for engineering chimeric antigen receptors (CAR) in modified CAR-T cells. Relfovetmab can be used in studies of cancer and immune disorders .
loading...
    loading...
Cat. No.: HY-157288
Research Areas:  

Metabolic Disease

(R)-Phe-A110/B319, a hapten, is a selective binder to tumor-associated antigens. (R)-Phe-A110/B319 has a 20-fold higher affinity towards the H1047R mutant of p110α in the p110α/p85α PI3K complex. (R)-Phe-A110/B319 can be used for the research of conditional chimeric antigen receptor T (CAR-T) cell activation and tumor targeting .
loading...
    loading...
Cat. No.: HY-185975
Target:  

mRNA

Research Areas:  

Others

Scarless CD19 CAR circular RNA (CVB3) is a circular RNA that uses CVB3 IRES to mediate scarless expression of the CD19 chimeric antigen receptor (CAR) for CAR-T cell research. This circular RNA features a scarless circularization design, eliminating the need for a linker or adapter sequence between the 5′ and 3′ ends, and achieving efficient circularization and expression without the need for optimized UTR elements.
loading...
    loading...
Cat. No.: HY-P11129
CAS No.: 289905-22-2
Target:  

Inhibitory Antibodies

Research Areas:  

Cancer

MAGE-A4 (286-294) is a polypeptide derived from the 286th to 294th amino acids of the MAGE-A4 protein. MAGE-A4 (286-294) binds HLA-­A*02 with an affinity of 560.08 nM and an IC50 of 8.52 nM. MAGE-A4 (286-294) can be detected in various types of cancers (such as esophageal cancer, lung squamous cell carcinoma, bladder cancer). MAGE-A4 (286-294) can be used to produce CAR-T cells and to develop CAR-T cell therapy .
loading...
    loading...